Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

NCT04121221

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Mapi Pharma Research site 08 Birmingham, Alabama, United States
  • Mapi Pharma Research site 11 Cullman, Alabama, United States
  • Mapi Pharma Research site 15 Pasadena, California, United States
  • Mapi Pharma Research site 14 Denver, Colorado, United States
View all 112 locations
View Trial Details
Completed

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

NCT05029206

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Sahlgrenska University Hospital Gothenburg, Sweden
  • Linköping University Hospital Linköping, Sweden
  • Skåne University Hospital Lund, Sweden
  • Örebro University Hospital Örebro, Sweden
View Trial Details
Completed

Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region

NCT04468165

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • CHU Frantz FANON Blida, Algeria
  • Nedir Mohamed Hospital Tizi Ouzou, Algeria
  • New University Hospital Alexandria, Egypt
  • Demerdash hospital (Ain Shams University) Cairo, Egypt
View Trial Details

Related conditions